| Ticker Details |
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$191.69B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.46 | 1.00%
|
| Avg Daily Range (30 D): |
$4.02 | 1.11%
|
| Avg Daily Range (90 D): |
$4.10 | 1.17%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.74M |
| Avg Daily Volume (30 D): |
1.79M |
| Avg Daily Volume (90 D): |
1.9M |
| Trade Size |
| Avg Trade Size (Sh.): |
129 |
| Avg Trade Size (Sh.) (30 D): |
30 |
| Avg Trade Size (Sh.) (90 D): |
30 |
| Institutional Trades |
| Total Institutional Trades: |
114,933 |
| Avg Institutional Trade: |
$6.57M |
| Avg Institutional Trade (30 D): |
$41.24M |
| Avg Institutional Trade (90 D): |
$43.52M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
20 |
| Market Closing Trades |
| Avg Closing Trade: |
$68.29M |
| Avg Closing Trade (30 D): |
$227.14M |
| Avg Closing Trade (90 D): |
$215.93M |
| Avg Closing Volume: |
392.67K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$14.33
|
$2.47
|
$14.33
|
|
Diluted EPS
|
$14.23
|
$2.46
|
$14.23
|
|
Revenue
|
$36.75B
|
$9.87B
|
$36.75B
|
|
Gross Profit
|
$24.71B
|
$6.89B
|
$24.71B
|
|
Net Income / Loss
|
$7.71B
|
$1.33B
|
$7.71B
|
|
Operating Income / Loss
|
$9.08B
|
$2.72B
|
$9.08B
|
|
Cost of Revenue
|
$12.04B
|
$2.98B
|
$12.04B
|
|
Net Cash Flow
|
$-2844M
|
$-316M
|
$-2844M
|
|
PE Ratio
|
24.74
|
|
|
|
|
|
